Work

วอทิออกซีทีน: ยาต้านเศร้าชนิดใหม่ที่ออกฤทธิ์ได้หลายรูปแบบ

Year: 2024
Type: article
Abstract: Currently, there are several effective antidepressant medications available for treating depression. However, some patients still do not fully recover and may experience residual symptoms. In addition to manage mood aspect, the management of cognitive function in depressive patient is important otherwise symptom will exacerbate. Vortioxetine is a multimodal antidepressant that blocks the serotonin reuptake transporter and several serotonin receptors. As a consequence, it can manage depression and reduce symptom of cognitive function. The drug is well absorbed with an average half-life of 66 hours and undergoes metabolism primarily via the CYP2D6 enzyme. Clinical efficacy of vortioxetine has been demonstrated in many studies both short term (6-12 weeks) and long term (52 weeks) studies. But the study that compared to other antidepressants shows no evidence for vortioxetine superiority in depression treatments. The most reported adverse effect is nausea. Vortioxetine dose of 10-20 mg/day has been approved by USFDA for treatment of depression in adults. The role of vortioxetine may be beneficial for patients with cognitive impairment or experiencing sexual dysfunction as adverse effects from other antidepressants.
Language: Thai
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7219423735
FWCI:
Cites: 31
Cited by:
Related to: 9